AR036048A1 - Compuesto de piperazina; composiciones farmaceuticas formuladas con dicho compuesto y uso de las sales difumarato de dicho compuesto, en la preparacion de composiciones farmaceuticas para el tratamiento de trastornos tromboticos - Google Patents

Compuesto de piperazina; composiciones farmaceuticas formuladas con dicho compuesto y uso de las sales difumarato de dicho compuesto, en la preparacion de composiciones farmaceuticas para el tratamiento de trastornos tromboticos

Info

Publication number
AR036048A1
AR036048A1 ARP020102199A ARP020102199A AR036048A1 AR 036048 A1 AR036048 A1 AR 036048A1 AR P020102199 A ARP020102199 A AR P020102199A AR P020102199 A ARP020102199 A AR P020102199A AR 036048 A1 AR036048 A1 AR 036048A1
Authority
AR
Argentina
Prior art keywords
compound
pharmaceutical compositions
crystallization
treatment
difumarate
Prior art date
Application number
ARP020102199A
Other languages
English (en)
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2001/002553 external-priority patent/WO2001096323A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR036048A1 publication Critical patent/AR036048A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP020102199A 2001-06-12 2002-06-11 Compuesto de piperazina; composiciones farmaceuticas formuladas con dicho compuesto y uso de las sales difumarato de dicho compuesto, en la preparacion de composiciones farmaceuticas para el tratamiento de trastornos tromboticos AR036048A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/GB2001/002553 WO2001096323A1 (en) 2000-06-13 2001-06-12 Serine protease inhibitors
US33929501P 2001-12-12 2001-12-12

Publications (1)

Publication Number Publication Date
AR036048A1 true AR036048A1 (es) 2004-08-04

Family

ID=41210812

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020102199A AR036048A1 (es) 2001-06-12 2002-06-11 Compuesto de piperazina; composiciones farmaceuticas formuladas con dicho compuesto y uso de las sales difumarato de dicho compuesto, en la preparacion de composiciones farmaceuticas para el tratamiento de trastornos tromboticos

Country Status (13)

Country Link
US (1) US20040162295A1 (de)
EP (1) EP1397348B1 (de)
JP (1) JP2004534062A (de)
AR (1) AR036048A1 (de)
AT (1) ATE305452T1 (de)
AU (1) AU2002348501A1 (de)
DE (1) DE60206376T2 (de)
ES (1) ES2248618T3 (de)
MY (1) MY137876A (de)
PE (1) PE20030198A1 (de)
SV (1) SV2003001085A (de)
TW (1) TWI257389B (de)
WO (1) WO2002100847A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7265121B2 (en) 2001-07-26 2007-09-04 Eli Lilly And Company Chemical compounds
PL373066A1 (en) 2002-04-01 2005-08-08 Eli Lilly And Company Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa
KR100849242B1 (ko) * 2004-06-30 2008-07-29 일라이 릴리 앤드 캄파니 1(인돌-6-카르보닐-d-페닐글리시닐)-4-(1-메틸피페리딘-4-일) 피페라진 d-타르트레이트
CN1984903A (zh) * 2004-06-30 2007-06-20 伊莱利利公司 1-(吲哚-6-羰基-d-苯基甘氨酰基)-4-(1-甲基哌啶-4-基)哌嗪d-酒石酸盐
DE102007028406A1 (de) 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
DE102007028319A1 (de) 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
DE102007028407A1 (de) 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
JP2015524400A (ja) * 2012-07-19 2015-08-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 9−[4−(3−クロロ−2−フルオロ−フェニルアミノ)−7−メトキシ−キナゾリン−6−イルオキシ]−1,4−ジアザ−スピロ[5.5]ウンデカン−5−オンのフマル酸塩、その薬物としての使用及び調製

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2375920A1 (en) * 1999-06-14 2000-12-21 Eli Lilly And Company Compounds
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds

Also Published As

Publication number Publication date
WO2002100847A3 (en) 2003-08-21
DE60206376T2 (de) 2006-06-22
TWI257389B (en) 2006-07-01
JP2004534062A (ja) 2004-11-11
EP1397348A2 (de) 2004-03-17
DE60206376D1 (de) 2006-02-09
ATE305452T1 (de) 2005-10-15
AU2002348501A1 (en) 2002-12-23
SV2003001085A (es) 2003-03-18
EP1397348B1 (de) 2005-09-28
ES2248618T3 (es) 2006-03-16
PE20030198A1 (es) 2003-03-12
WO2002100847A2 (en) 2002-12-19
US20040162295A1 (en) 2004-08-19
MY137876A (en) 2009-03-31

Similar Documents

Publication Publication Date Title
US6469026B2 (en) Isoquinolone inhibitors of factor Xa
NO20052311L (no) Mandelsyrederivater.
NZ514477A (en) Adamantane derivatives
YU104592A (sh) Novi peptidni derivati
MEP43008A (en) Indole-2-carboxamides as factor xa inhibitors
BR112022025198A2 (pt) Formas sólidas do inibidor de apol1 e uso das mesmas
GEP20063871B (en) Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
CY1111693T1 (el) Αντιιικοι παραγοντες
MY143400A (en) 2-pyridone derivatives as neutrophil elastase inhibitors and their use
HUP0303538A2 (hu) Tirozin kinázok Tec családjának tiazolil-vegyület inhibitorai és ezeket tartalmazó gyógyszerkészítmények
DK0821685T3 (da) Indol-3-carbonyl- og indol-3-sulfonyl-derivater som antagonister mod blodpladeaktiverende faktor
ATE390415T1 (de) Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung
NO20075781L (no) Diarylsulfone-sulfonamider og deres anvendelse
WO2001057003A1 (en) 3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE INHIBITORS OF FACTOR Xa
RU2125450C1 (ru) Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина
UA74372C2 (uk) Інгібітори серинових протеаз, фармацевтична композиція на їх основі
CA2370244A1 (en) Piperidine derivatives
NO20005497D0 (no) Heterocykliske derivater som inhiberer faktor Xa
ATE368643T1 (de) Faktor xa benzamidin inhibitoren
EP1255741A2 (de) 2-(1h)-chinolinone und 2-(1h)-chinoxalinone inhibitoren von xa faktor
ECSP024244A (es) Uso de (z)-2-cyano-3-hydroxy-but-2-enoic acid(4´-trifluoromethylphenyl)-amide para el tratamiento de la esclerosis múltiple
CA2448058A1 (en) Pyrazole derivatives as hiv reverse transcriptase inhibitors
WO2002032901A3 (en) Bridged piperazine derivatives
MXPA02012409A (es) Derivados de pirrol para tratamiento del sida.
AR019871A1 (es) Una composicion farmaceutica que comprende inhibidores del factor de transcripcion nf-kb y el uso de los mismos para la manufactura de un medicamento

Legal Events

Date Code Title Description
FB Suspension of granting procedure